A recent paper reports that the use of the drug tenecteplase, not yet approved for stroke treatment in the U.S., may lead to ...

Grand Itasca Clinic and Hospital is proud to announce its redesignation as an Acute Stroke Ready Hospital (ASRH), a status it ...

For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and ...

For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and ...

More vigilance may be needed regarding the amount of benzodiazepines being dispensed to older stroke survivors, though ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER ...

This article explores the effectiveness and safety of Tenecteplase vs Alteplase for treating acute ischemic stroke. The right ...

S100β levels 24 hours after IVT were independently associated with HT, infarct volume, and prognosis in stroke patients ...

Tenecteplase is a third-generation thrombolytic agent that has a favourable pharmacological profile, compared with alteplase.

Early antihypertensive treatment may lead to functional dependency or death at 90 days in patients with stroke with PAD stenosis.

Pediatric stroke is among the leading causes of death and disability in children. Advances in adult stroke recognition, triage, and management have greatly changed stroke systems of care in recent ...